• Transferrin identified as potential cont

    From ScienceDaily@1337:3/111 to All on Mon Aug 3 21:30:28 2020
    Transferrin identified as potential contributor to COVID-19 severity


    Date:
    August 3, 2020
    Source:
    University of Kent
    Summary:
    Researchers have identified that a glycoprotein known as transferrin
    may critically contribute to severe forms of COVID-19.



    FULL STORY ==========================================================================
    The University of Kent's School of Biosciences and the Institute of
    Medical Virology at Goethe-University, Frankfurt am Main, have identified
    that a glycoprotein known as transferrin may critically contribute to
    severe forms of COVID-19.


    ========================================================================== SARS-CoV-2 is the coronavirus that causes COVID-19. It is currently
    not known why some individuals develop only mild or no symptoms when
    infected, whilst others experience severe, life-threatening forms of
    the disease. However, it is known that the risk of COVID-19 becoming
    severe increases with age and is higher in males than in females. Many
    severe COVID-19 cases are characterised by increased blood clotting and thrombosis formation.

    The team combined existing data on gene expression in humans and infected
    cells to search for molecules involved in blood coagulation that differ
    between females and males, change with age, and are regulated in response
    to SARS-CoV- 2 infection.

    Out of more than 200 candidate factors, researchers identified a
    glycoprotein called transferrin to be a procoagulant (a cause of blood clotting) that increases with age, is higher in males than in females,
    and is higher in SARS- CoV-2-infected cells. Hence, transferrin may
    have potential as a biomarker for the early identification of COVID-19
    patients at high risk of severe disease.

    Katie-May McLaughlin, the first author of the study said: "It is very
    exciting to be involved in such an important study that may improve
    therapies for COVID- 19 in its most severe form."

    ========================================================================== Story Source: Materials provided by University_of_Kent. Original written
    by Sam Wood. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Katie-May McLaughlin, Marco Bechtel, Denisa Bojkova, Christian
    Mu"nch,
    Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich
    Cinatl. COVID-19- Related Coagulopathy -- Is Transferrin
    a Missing Link? Diagnostics, 2020; 10 (8): 539 DOI:
    10.3390/diagnostics10080539 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2020/08/200803120139.htm

    --- up 2 weeks, 5 days, 1 hour, 55 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)